药物动力学服务市场－全球产业规模、份额、趋势、机会和预测，按药物类型、应用、最终用途、地区和竞争格局划分，2020-2030年预测

2024年全球药物动力学服务市场规模为10.7436亿美元，预计2030年将以8.2%的复合年增长率成长至17.2391亿美元。药物动力学（PK）服务涵盖对药物在生物系统中的吸收、分布、代谢和排泄（ADME）的科学分析，在优化治疗剂量、提高药物疗效以及确保临床前和临床开发过程中的合规性方面发挥关键作用。推动这项关键服务市场成长的主要因素包括：全球医药研发投入的不断增加、包括生物製剂在内的新型药物实体日益复杂化以及对个人化医疗策略的日益重视。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球药物动力学服务市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依药物类型（小分子、大分子）
  • 依申请方式（中小企业、大型企业）
  • 按最终用途划分（生物技术和製药公司、学术和政府研究机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美药物动力学服务市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲药物动力学服务市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区药物动力学服务市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲药物动力学服务市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲药物动力学服务市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球药物动力学服务市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Evotec AG
• Certara, LP
• Pacific BioLabs
• GVK Biosciences Private Limited
• Shanghai Medicilon Inc.
• Pharmaceutical Product Development, LLC
• Charles River Laboratories International, Inc.
• PAREXEL International Corporation
• Eurofins Scientific SE
• Frontage Labs

第十六章：策略建议

第17章调查会社について・免责事项

The Global Pharmacokinetics Services Market, valued at USD 1074.36 Million in 2024, is projected to experience a CAGR of 8.2% to reach USD 1723.91 Million by 2030. Pharmacokinetics (PK) services encompass the scientific analysis of drug absorption, distribution, metabolism, and excretion (ADME) within biological systems, playing a pivotal role in optimizing therapeutic dosages, enhancing drug efficacy, and ensuring regulatory compliance throughout preclinical and clinical development. The market for these essential services is primarily propelled by increasing global pharmaceutical research and development investments, the rising complexity of novel drug entities including biologics, and the expanding focus on personalized medicine strategies.

Key Market Drivers

The global pharmacokinetics services market is significantly driven by the rising complexity of drug development and the increasing demand for biopharmaceuticals. Modern drug development increasingly targets intricate novel entities, especially for rare diseases and personalized medicine, which necessitates highly specialized pharmacokinetic analysis. This heightened complexity demands sophisticated study designs and advanced analytical techniques to understand drug behavior in diverse patient populations. According to a research article in the British Journal of Pharmacology, in March 2024, "Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review," over half of the seventy novel drugs authorized in 2023 targeted rare diseases or intractable forms of cancer, underscoring this industry shift towards challenging therapeutic areas.

Key Market Challenges

The substantial costs and inherent complexities associated with conducting advanced pharmacokinetic (PK) studies present a significant impediment to the growth of the Global Pharmacokinetics Services Market. The specialized equipment, highly skilled personnel, and extensive validation required for these studies, particularly for complex biologics and personalized therapies, translate into considerable financial outlays. This financial burden can restrict the number of drug candidates that companies, especially smaller biotechnology firms, can advance into development, thereby limiting the overall demand for PK services.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning into pharmacokinetic modeling represents a pivotal trend reshaping drug development by enhancing efficiency and predictive accuracy. These advanced computational methods enable the processing of extensive datasets, improving the prediction of drug absorption, distribution, metabolism, and excretion (ADME) properties with greater precision than traditional approaches. According to a December 2023 survey by Rackspace Technology and Dell/VMware, 68% of pharmaceutical businesses identified pervasive AI as having the highest potential impact on their business, indicating a strong industry recognition of this technology's transformative power. This integration allows for more informed decision-making earlier in the development pipeline, potentially reducing the need for costly in vivo experiments and accelerating the identification of promising drug candidates.

Key Market Players

• Evotec AG
• Certara, L.P.
• Pacific BioLabs
• GVK Biosciences Private Limited
• Shanghai Medicilon Inc.
• Pharmaceutical Product Development, LLC
• Charles River Laboratories International, Inc.
• PAREXEL International Corporation
• Eurofins Scientific SE
• Frontage Labs

Report Scope:

In this report, the Global Pharmacokinetics Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmacokinetics Services Market, By Drug Type:

• Small Molecules
• Large Molecules

Pharmacokinetics Services Market, By Application:

• Small and Medium Enterprise
• Large Enterprise

Pharmacokinetics Services Market, By End-Use:

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

Pharmacokinetics Services Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmacokinetics Services Market.

Available Customizations:

Global Pharmacokinetics Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmacokinetics Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Type (Small Molecules, Large Molecules)
  • 5.2.2. By Application (Small and Medium Enterprise, Large Enterprise)
  • 5.2.3. By End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Pharmacokinetics Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Type
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmacokinetics Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Pharmacokinetics Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Pharmacokinetics Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Pharmacokinetics Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmacokinetics Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Pharmacokinetics Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Pharmacokinetics Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Pharmacokinetics Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Pharmacokinetics Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Pharmacokinetics Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Type
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmacokinetics Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Pharmacokinetics Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Pharmacokinetics Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Pharmacokinetics Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Pharmacokinetics Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Pharmacokinetics Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Type
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmacokinetics Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Pharmacokinetics Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Pharmacokinetics Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. South America Pharmacokinetics Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Type
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmacokinetics Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Pharmacokinetics Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Pharmacokinetics Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmacokinetics Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Evotec AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Certara, L.P.
• 15.3. Pacific BioLabs
• 15.4. GVK Biosciences Private Limited
• 15.5. Shanghai Medicilon Inc.
• 15.6. Pharmaceutical Product Development, LLC
• 15.7. Charles River Laboratories International, Inc.
• 15.8. PAREXEL International Corporation
• 15.9. Eurofins Scientific SE
• 15.10. Frontage Labs

16. Strategic Recommendations

17. About Us & Disclaimer